SYPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.621800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.742400E-01
Normal-vs-Stage2
8.657600E-01
Normal-vs-Stage3
4.868200E-01
Normal-vs-Stage4
4.327400E-01
Stage1-vs-Stage2
6.638800E-01
Stage1-vs-Stage3
5.487000E-01
Stage1-vs-Stage4
2.794800E-01
Stage2-vs-Stage3
3.252400E-01
Stage2-vs-Stage4
3.023400E-01
Stage3-vs-Stage4
1.999010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.817800E-01
Normal-vs-AfricanAmerican
6.685400E-01
Normal-vs-Asian
8.852800E-01
Caucasian-vs-AfricanAmerican
5.140000E-01
Caucasian-vs-Asian
7.329200E-01
AfricanAmerican-vs-Asian
4.830400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.900600E-01
Normal-vs-Female
9.418200E-01
Male-vs-Female
4.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.354000E-01
Normal-vs-Age(41-60Yrs)
6.141000E-01
Normal-vs-Age(61-80Yrs)
8.305000E-01
Normal-vs-Age(81-100Yrs)
9.809600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.140400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.981400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.885400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.135300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.451800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.492600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.932000E-01
Normal-vs-Daily Drinker
9.422800E-01
Normal-vs-Weekly Drinker
8.033200E-01
Normal-vs-Occasional Drinker
9.028800E-01
Normal-vs-Social Drinker
7.365400E-01
Non Drinker-vs-Daily Drinker
3.023600E-01
Non Drinker-vs-Weekly Drinker
2.482400E-01
Non Drinker-vs-Occasional Drinker
3.966600E-01
Non Drinker-vs-Social Drinker
2.090800E-01
Daily Drinker-vs-Weekly Drinker
7.278600E-01
Daily Drinker-vs-Occasional Drinker
7.326000E-01
Daily Drinker-vs-Social Drinker
6.999800E-01
Weekly Drinker-vs-Occasional Drinker
4.967600E-01
Weekly Drinker-vs-Social Drinker
9.882600E-01
Occasional Drinker-vs-Social Drinker
4.128000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.601600E-02
Normal-vs-Grade 2
2.915700E-03
Normal-vs-Grade 3
8.219200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.639390E-03
Grade 1-vs-Grade 3
4.283400E-03
Grade 1-vs-Grade 4
4.601600E-02
Grade 2-vs-Grade 3
7.000200E-01
Grade 2-vs-Grade 4
2.915700E-03
Grade 3-vs-Grade 4
8.219200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.863800E-01
Normal-vs-NonDiabetic
9.482000E-01
Diabetic-vs-NonDiabetic
5.185800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.326400E-01
Normal-vs-NoPancreatitis
9.813800E-01
Pancreatitis-vs-NoPancreatitis
3.262600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.705000E-01
Normal-vs-N1
9.235000E-01
N0-vs-N1
8.492600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.176000E-01
Normal-vs-TP53-NonMutant
8.473800E-01
TP53-Mutant-vs-TP53-NonMutant
9.029200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
